Generic Abuse Deterrent Opioids: FDA Offers Tier-Based Testing Approach
This article was originally published in The Pink Sheet Daily
Executive Summary
Draft guidance provides roadmap for testing generic solid oral opioid products; FDA's Califf notes difficulty in conducting post-market studies.